Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Losartan | 3 | 2021 | 299 | 0.790 |
Why?
|
Mammary Neoplasms, Experimental | 4 | 2021 | 520 | 0.790 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 3 | 2021 | 451 | 0.730 |
Why?
|
Radiation Tolerance | 5 | 2017 | 486 | 0.700 |
Why?
|
Neoplasm Transplantation | 11 | 2014 | 2085 | 0.540 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2022 | 2214 | 0.460 |
Why?
|
Receptors, CXCR4 | 5 | 2019 | 726 | 0.460 |
Why?
|
Phenylurea Compounds | 4 | 2020 | 528 | 0.460 |
Why?
|
Glioblastoma | 5 | 2021 | 3481 | 0.420 |
Why?
|
Rodent Diseases | 1 | 2011 | 57 | 0.400 |
Why?
|
Mice, SCID | 6 | 2016 | 2716 | 0.380 |
Why?
|
Niacinamide | 3 | 2017 | 417 | 0.340 |
Why?
|
Liver Neoplasms | 7 | 2022 | 4253 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2019 | 546 | 0.330 |
Why?
|
Transplantation, Heterologous | 10 | 2015 | 2382 | 0.330 |
Why?
|
Neoplasms, Experimental | 3 | 2019 | 1276 | 0.330 |
Why?
|
Tumor Cells, Cultured | 10 | 2021 | 6314 | 0.320 |
Why?
|
Mice | 50 | 2024 | 81183 | 0.310 |
Why?
|
Neovascularization, Pathologic | 6 | 2019 | 2635 | 0.310 |
Why?
|
Liver Neoplasms, Experimental | 2 | 2021 | 191 | 0.310 |
Why?
|
Mice, Nude | 13 | 2019 | 3689 | 0.280 |
Why?
|
Tumor Microenvironment | 8 | 2024 | 3586 | 0.270 |
Why?
|
Animals | 58 | 2024 | 168757 | 0.260 |
Why?
|
Immunotherapy | 5 | 2021 | 4445 | 0.260 |
Why?
|
Stress, Mechanical | 3 | 2020 | 1686 | 0.250 |
Why?
|
Brain Neoplasms | 5 | 2020 | 8863 | 0.250 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 449 | 0.240 |
Why?
|
Neurofibromatosis 2 | 2 | 2019 | 380 | 0.230 |
Why?
|
Radiotherapy Dosage | 6 | 2023 | 2879 | 0.230 |
Why?
|
Cell Line, Tumor | 15 | 2021 | 16689 | 0.230 |
Why?
|
Neuroma, Acoustic | 2 | 2019 | 451 | 0.230 |
Why?
|
Disease Models, Animal | 13 | 2023 | 18029 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3508 | 0.210 |
Why?
|
Sarcoma | 5 | 1996 | 1897 | 0.210 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 42 | 0.200 |
Why?
|
MicroRNAs | 1 | 2017 | 3752 | 0.200 |
Why?
|
Sciatica | 1 | 2021 | 98 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 5172 | 0.180 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2014 | 547 | 0.180 |
Why?
|
Chemokine CXCL10 | 1 | 2020 | 304 | 0.170 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.170 |
Why?
|
Osteosarcoma | 1 | 2005 | 881 | 0.170 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2023 | 2988 | 0.170 |
Why?
|
Cerebellopontine Angle | 1 | 2019 | 55 | 0.170 |
Why?
|
Angiogenesis Inhibitors | 3 | 2022 | 2038 | 0.170 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 516 | 0.160 |
Why?
|
Receptor, erbB-2 | 2 | 2021 | 2416 | 0.160 |
Why?
|
Breast Neoplasms | 7 | 2023 | 20822 | 0.160 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2016 | 152 | 0.160 |
Why?
|
Cisplatin | 1 | 2024 | 1662 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13102 | 0.150 |
Why?
|
Protons | 1 | 2023 | 1127 | 0.150 |
Why?
|
Mice, Inbred C3H | 5 | 2015 | 964 | 0.150 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2016 | 118 | 0.140 |
Why?
|
Elasticity | 1 | 2018 | 657 | 0.140 |
Why?
|
Implants, Experimental | 1 | 2016 | 104 | 0.140 |
Why?
|
Th1 Cells | 1 | 2021 | 1057 | 0.130 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 1991 | 286 | 0.130 |
Why?
|
Lithium | 1 | 2019 | 601 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11524 | 0.130 |
Why?
|
Maytansine | 1 | 2015 | 80 | 0.130 |
Why?
|
Pathology | 1 | 2018 | 272 | 0.130 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1889 | 0.120 |
Why?
|
Indomethacin | 1 | 1995 | 332 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2015 | 1863 | 0.120 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2014 | 117 | 0.120 |
Why?
|
Neoplasms | 5 | 2019 | 21683 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 76 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4479 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 813 | 0.120 |
Why?
|
Minocycline | 1 | 2014 | 163 | 0.120 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 353 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2023 | 3474 | 0.110 |
Why?
|
Hyperalgesia | 1 | 2017 | 502 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 924 | 0.110 |
Why?
|
Nasopharyngitis | 2 | 1991 | 10 | 0.110 |
Why?
|
Bone Neoplasms | 1 | 2005 | 2529 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2017 | 13695 | 0.110 |
Why?
|
Spinal Cord | 1 | 2021 | 1809 | 0.110 |
Why?
|
Scattering, Radiation | 1 | 2014 | 498 | 0.110 |
Why?
|
Angiotensins | 1 | 2013 | 151 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2014 | 401 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 464 | 0.100 |
Why?
|
Intestines | 1 | 2021 | 1924 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2017 | 850 | 0.100 |
Why?
|
Hearing Loss | 1 | 2019 | 765 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 687 | 0.100 |
Why?
|
Drug Delivery Systems | 3 | 2019 | 2219 | 0.100 |
Why?
|
Receptors, Chemokine | 1 | 2014 | 669 | 0.090 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2924 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2011 | 201 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2114 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 594 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.090 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 534 | 0.080 |
Why?
|
Myeloid Cells | 1 | 2014 | 810 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2825 | 0.080 |
Why?
|
Nasopharynx | 1 | 1991 | 379 | 0.080 |
Why?
|
Thymus Neoplasms | 1 | 2011 | 268 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 625 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10180 | 0.080 |
Why?
|
Female | 26 | 2023 | 380194 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 3 | 2015 | 876 | 0.080 |
Why?
|
Lymphokines | 1 | 2011 | 949 | 0.080 |
Why?
|
Male | 25 | 2021 | 350118 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.080 |
Why?
|
Mice, Knockout | 6 | 2021 | 14557 | 0.080 |
Why?
|
Random Allocation | 3 | 2017 | 2429 | 0.070 |
Why?
|
Stromal Cells | 4 | 2016 | 1355 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5256 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 21827 | 0.070 |
Why?
|
Neurofibromin 2 | 2 | 2019 | 267 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1070 | 0.070 |
Why?
|
Spheroids, Cellular | 2 | 2019 | 351 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1376 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7322 | 0.070 |
Why?
|
Nasal Mucosa | 1 | 1989 | 373 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2021 | 9734 | 0.070 |
Why?
|
Adenocarcinoma | 3 | 2003 | 6364 | 0.070 |
Why?
|
Nanoparticles | 1 | 2017 | 1905 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 1995 | 1363 | 0.060 |
Why?
|
Carbon Tetrachloride | 2 | 2015 | 64 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2017 | 10481 | 0.060 |
Why?
|
Humans | 32 | 2024 | 744343 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 1996 | 2541 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.060 |
Why?
|
Brain | 4 | 2020 | 26385 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 1991 | 2942 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1995 | 4420 | 0.060 |
Why?
|
Sarcoma, Experimental | 1 | 2003 | 128 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2021 | 1821 | 0.060 |
Why?
|
Monte Carlo Method | 2 | 2020 | 1254 | 0.050 |
Why?
|
Tibia | 1 | 2008 | 1077 | 0.050 |
Why?
|
Pain | 1 | 2017 | 4986 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2016 | 3143 | 0.050 |
Why?
|
Tumor Burden | 2 | 2016 | 1915 | 0.050 |
Why?
|
Neuroprotective Agents | 2 | 2019 | 941 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2148 | 0.050 |
Why?
|
Inflammation | 2 | 2018 | 10638 | 0.040 |
Why?
|
Nitrosamines | 2 | 1991 | 87 | 0.040 |
Why?
|
Cell Survival | 3 | 2018 | 5882 | 0.040 |
Why?
|
Compressive Strength | 1 | 2020 | 169 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4262 | 0.040 |
Why?
|
Signal Transduction | 5 | 2016 | 23403 | 0.040 |
Why?
|
Antibodies | 2 | 2019 | 2460 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1970 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 730 | 0.040 |
Why?
|
Photons | 1 | 2023 | 588 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 2019 | 230 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
Hearing Tests | 1 | 2019 | 122 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 1995 | 226 | 0.040 |
Why?
|
Graft Survival | 1 | 1989 | 3737 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7474 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 6770 | 0.040 |
Why?
|
Pain Threshold | 1 | 2021 | 584 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4851 | 0.040 |
Why?
|
Muscle Cells | 1 | 2018 | 197 | 0.040 |
Why?
|
Luciferases | 1 | 2019 | 733 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2019 | 536 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2018 | 643 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1836 | 0.040 |
Why?
|
Etoposide | 1 | 1998 | 641 | 0.030 |
Why?
|
Transfection | 2 | 2014 | 5892 | 0.030 |
Why?
|
Rotarod Performance Test | 1 | 2015 | 64 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 7729 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2689 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2016 | 151 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 1995 | 5686 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
Dimethylpolysiloxanes | 1 | 2016 | 149 | 0.030 |
Why?
|
Apoptosis | 4 | 2015 | 9727 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 2014 | 77 | 0.030 |
Why?
|
Hearing | 1 | 2019 | 482 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8301 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2019 | 1547 | 0.030 |
Why?
|
Indoles | 1 | 2023 | 1839 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 2014 | 90 | 0.030 |
Why?
|
Hindlimb | 1 | 1996 | 504 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7799 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2003 | 9274 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1360 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2023 | 2258 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2557 | 0.030 |
Why?
|
Cricetinae | 1 | 1998 | 2472 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12745 | 0.030 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2014 | 180 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8642 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 809 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2617 | 0.030 |
Why?
|
Cell Line | 3 | 2017 | 15997 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3206 | 0.030 |
Why?
|
Cell Movement | 2 | 2016 | 5217 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2021 | 1881 | 0.030 |
Why?
|
Connective Tissue Growth Factor | 1 | 2013 | 96 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11366 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 767 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 270 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2015 | 349 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Sciatic Nerve | 1 | 2015 | 607 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2645 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 3 | 1995 | 4034 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4456 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2018 | 1877 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1621 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2018 | 19229 | 0.030 |
Why?
|
Edema | 1 | 2015 | 789 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2013 | 314 | 0.020 |
Why?
|
Nitrites | 1 | 2011 | 160 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 229 | 0.020 |
Why?
|
Rats | 3 | 2017 | 24260 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 972 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4149 | 0.020 |
Why?
|
Blood Vessels | 1 | 2016 | 1125 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 675 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2015 | 788 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
Cell Division | 3 | 2004 | 4568 | 0.020 |
Why?
|
Nitrates | 1 | 2011 | 265 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4364 | 0.020 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 491 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2029 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2011 | 315 | 0.020 |
Why?
|
Carcinogens | 1 | 1991 | 466 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1770 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 644 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1792 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 1988 | 54 | 0.020 |
Why?
|
Neurogenesis | 1 | 2014 | 838 | 0.020 |
Why?
|
Kinetics | 1 | 1996 | 6473 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 1989 | 385 | 0.020 |
Why?
|
Fluorouracil | 1 | 2013 | 1619 | 0.020 |
Why?
|
DNA Damage | 1 | 1998 | 2432 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3582 | 0.020 |
Why?
|
Mucous Membrane | 1 | 1991 | 673 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1736 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 541 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2011 | 476 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3420 | 0.020 |
Why?
|
Neuroblastoma | 1 | 1995 | 1226 | 0.020 |
Why?
|
Plants, Medicinal | 1 | 1988 | 167 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3505 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2011 | 571 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9239 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4161 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1991 | 806 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1379 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6622 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1634 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2234 | 0.020 |
Why?
|
Body Weight | 1 | 1995 | 4669 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2016 | 3279 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3719 | 0.010 |
Why?
|
Carcinoma | 1 | 1995 | 2375 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3584 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2011 | 2216 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 2003 | 257 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7181 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2488 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2008 | 1928 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9438 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9338 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 2942 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12720 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 5102 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.010 |
Why?
|
Time Factors | 2 | 1996 | 40075 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8428 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.010 |
Why?
|
Chronic Disease | 1 | 1989 | 9146 | 0.010 |
Why?
|
HeLa Cells | 2 | 1990 | 3128 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14722 | 0.010 |
Why?
|
Carcinogenicity Tests | 1 | 1989 | 41 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11727 | 0.010 |
Why?
|
Spleen | 1 | 1989 | 2362 | 0.000 |
Why?
|
Adolescent | 1 | 1989 | 85781 | 0.000 |
Why?
|
Middle Aged | 1 | 1989 | 213383 | 0.000 |
Why?
|
Adult | 1 | 1989 | 214055 | 0.000 |
Why?
|